Scores here are heuristic signals about sourcing and corroboration across outlets — not verdicts on whether a story is true, and not an endorsement or condemnation of any outlet. How this works
Lab studies have shown that psychedelics like psilocybin can lower inflammation and may be protective for a range of illnesses. Now, researchers are publishing some of the first data in humans that signals this holds potential for patients with neurodegenerative diseases like Parkinson's disease.
1
independent outlets · 100% owner-diverse
Save this story
Connect "New human data hints at psychedelics' potential to combat inflammation" to your own research notes and market positions — Next Level Intelligence links what you save to the assets and notes it actually affects.